| | Editorial Foreword Botulinum toxin – From WMD to therapeutic agent and cosmetic aid Roger M Pinder PMCID: PMC2656310 Reviews Neuropsychological assessment, neuroimaging, and neuropsychiatric evaluation in pediatric and adult patients with sickle cell disease (SCD) Christopher L Edwards, Renee Dunn Raynor, Miriam Feliu, Camela McDougald, Stephanie Johnson, Donald Schmechel, Mary Wood, Gary G Bennett, Patrick Saurona, Melanie Bonner, Chante’ Wellington, Laura M DeCastro, Elaine Whitworth, Mary Abrams, Patrick Logue, Lekisha Edwards, Salutario Martinez, and Keith E Whitfield PMCID: PMC2656311 Role of endocannabinoids in regulating drug dependence Daniela Parolaro, Daniela Vigano, Natalia Realini, and Tiziana Rubino PMCID: PMC2656312 Management of epilepsy in the elderly Juan José Poza PMCID: PMC2656313 Treatment of myoclonic seizures in patients with juvenile myoclonic epilepsy Stéphane Auvin PMCID: PMC2656314 Sleep disturbances and suicide risk: A review of the literature Rebecca A Bernert and Thomas E Joiner PMCID: PMC2656315 A review on primary progressive aphasia Gabriel C Léger and Nancy Johnson PMCID: PMC2656316 Adult neural stem cells: The promise of the future Philippe Taupin PMCID: PMC2656317 Review of botulinum toxin type A for the prophylactic treatment of chronic daily headache Stefan Evers PMCID: PMC2656318 Expert Opinion Indiplon in the treatment of sleep disorders Alan Lankford PMCID: PMC2656319 Rivastigmine for the treatment of dementia associated with Parkinson’s disease Jennifer L Reingold, John C Morgan, and Kapil D Sethi PMCID: PMC2656320 Neurologic uses of botulinum neurotoxin type A John P Ney and Kevin R Joseph PMCID: PMC2656321 Almotriptan in the treatment of migraine Giorgio Sandrini, Armando Perrotta, Natalia L Arce Leal, Simona Buscone, and Giuseppe Nappi PMCID: PMC2656322 Topiramate in the treatment of partial and generalized epilepsy Edward Faught PMCID: PMC2656323 Ziprasidone in the treatment of mania in bipolar disorder Stephen E Nicolson and Charles B Nemeroff PMCID: PMC2656324 The therapeutic potential of escitalopram in the treatment of panic disorder Mark H Townsend and Erich J Conrad PMCID: PMC2656325 Extended-release divalproex in bipolar and other psychiatric disorders: A comprehensive review Steven C Stoner and Megan M Dahmen PMCID: PMC2656326 Update on quetiapine in the treatment of bipolar disorder: results from the BOLDER studies Prashant Gajwani, David J Muzina, David E Kemp, Keming Gao, and Joseph R Calabrese PMCID: PMC2656327 A review of quetiapine in combination with antidepressant therapy in patients with depression Ella J Daly and Madhukar H Trivedi PMCID: PMC2656328 Paliperidone ER: a review of the clinical trial data Philip G Janicak and Elizabeth A Winans PMCID: PMC2656329 Clinical use of pregabalin in the management of central neuropathic pain Nanna B Finnerup and Troels S Jensen PMCID: PMC2656330 Original Research What is the impact of physician communication and patient understanding in the management of headache? Meenal Patwardhan, Remy R Coeytaux, Rajeshwari Deshmukh, and Gregory Samsa PMCID: PMC2656331 Depressive mixed state: Evidence for a new form of depressive state in type I and II bipolar patients Katia M’Bailara, Donatienne Van den Bulke, Nicolas Demazeau, Jacques Demotes-Mainard, and Chantal Henry PMCID: PMC2656332 The patients’ perspective: Results of a survey assessing knowledge about and attitudes toward depression in PD Irene Hegeman Richard, Kori A LaDonna, Rosanne Hartman, Carol Podgorski, Roger Kurlan, and SAD-PD Study Group PMCID: PMC2656333 Rule knowledge aids performance on spatial and object alternation tasks by alcoholic patients with and without Korsakoff’s amnesia Fiona J Bardenhagen, Marlene Oscar-Berman, and Stephen C Bowden PMCID: PMC2656334 Repetitive transcranial magnetic stimulation for treatment of elderly patients with depression – an open label trial Gaby Abraham, Roumen Milev, Lauren Lazowski, Ruzica Jokic, Regina du Toit, and Alan Lowe PMCID: PMC2656335 Catechol-O-methyltransferase Val158Met genotype in healthy and personality disorder individuals: Preliminary results from an examination of cognitive tests hypothetically differentially sensitive to dopamine functions Winnie W Leung, Margaret M McClure, Larry J Siever, Deanna M Barch, and Philip D Harvey PMCID: PMC2656336 Urban–rural differences in pediatric traumatic head injuries: A prospective nationwide study Jonas G Halldorsson, Kjell M Flekkoy, Kristinn R Gudmundsson, Gudmundur B Arnkelsson, and Eirikur Orn Arnarson PMCID: PMC2656337 Rivastigmine in Chinese patients with subcortical vascular dementia Vincent Mok, Adrian Wong, Simon Ho, Thomas Leung, Wynnie WM Lam, and Ka Sing Wong PMCID: PMC2656338 Effects of psycho-educational training and stimulant medication on visual perceptual skills in children with attention deficit hyperactivity disorder Antigone S Papavasiliou, Irene Nikaina, Ioanna Rizou, and Stratos Alexandrou PMCID: PMC2656339 Cognitive decline tracks motor progression and not disease duration in Parkinson patients BD Riggeal, GP Crucian, P Seignourel, CE Jacobson, IV, MS Okun, RL Rodriguez, and Hubert H Fernandez PMCID: PMC2656340 Early rising children are more active than late risers Jun Kohyama PMCID: PMC2656341 Case Reports Pharmacogenetics of antipsychotic adverse effects: Case studies and a literature review for clinicians Adriana Foster, Zixuan Wang, Manzoor Usman, Edna Stirewalt, and Peter Buckley PMCID: PMC2656342 Towards a cognitive stimulation program using an errorless learning paradigm in amnestic mild cognitive impairment Léonie Jean, Martine Simard, Robert van Reekum, and Marie-Ève Bergeron PMCID: PMC2656343 Improvement of advanced postvaccinal demyelinating encephalitis due to plasmapheresis Andreas Rogalewski, Jörg Kraus, Martin Hasselblatt, Christoffer Kraemer, and Wolf-Rüdiger Schäbitz PMCID: PMC2656344 |
